NBIX   $125.7  0.56% Market Closed After Close 125.65 -0.04%

Neurocrine Biosciences Inc
Total Cash 1.23B
totalCashPerShare 12.129
EBITDA 628.00M
Total Debt 286.20M
quickRatio 3.977
currentRatio 4.367
Total Revenue 2.24B
debtToEquity 10.526
Revenue/Share 22.422
ROA 0.11795
ROE 0.16348
grossProfits
freeCashflow 328.06M
operatingCashflow 476.40M
earningsGrowth 0.51
revenueGrowth 0.247
grossMargins 0.68067
ebitdaMargins 0.28000998
operatingMargins 0.29705998
profitMargins 0.17206
enterpriseValue 11.36B
forwardPE 20.417887
floatShares 100.05M
sharesOutstanding 101.25M
sharesShort 2.62M
sharesShortPriorMonth 2.23M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.97%
Short Ratio help_outline 3.19%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 26.867
Price To Book help_outline 4.67
earningsQuarterlyGrowth 0.56
netIncomeToCommon 385.90M
trailingEps 3.76%
forwardEps 6.15%
enterpriseToEbitda 18.09
lastDividendValue
lastDividendDate
currentQuarterEstimate 1.61 4Q 2024
institutionsCount 876
lastUpdated Nov. 6, 2024, 8:24 p.m.